Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Al-Aloul, B. Al-Sheklly, J. Salai, B. Isalska (Manchester, United Kingdom). Microbiological impact of regular colistin use in a population of lung transplant recipients. Eur Respir J 2012; 40: Suppl. 56, 2446

Member's Comments

No comment yet.

Related content which might interest you: Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients Source: Eur Respir J 2007; 30: Suppl. 51, 176s Year: 2007 Evaluation of the biological effects of atorvastatin in lung transplant recipients Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 Prevalence of SDB in lung transplant recipients Source: Breathe 2010; 6: 274 Year: 2010 Safety and efficacy of outpatient bronchoscopy in lung transplant recipients: A single centre retrospective analysis Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play Year: 2011 Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Improving lung transplant outcomes in France: the high emergency lung transplantation programme Source: Eur Respir J, 59 (1) 2102209; 10.1183/13993003.02209-2021 Year: 2022 Covid 19 in a lung transplant population Source: Virtual Congress 2021 – Challenging problems in lung transplantation Year: 2021 Feasibility of smartphone-based physical activity tele-coaching in lung transplant recipients Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine Year: 2021 Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Antibiotic use in special populations: renal failure and the obese patient Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Aspergillus infections in lung transplant recipients. Risk factors and outcome Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Impact of donor, recipient and matching on survival after high emergency lung transplantation in France Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019 Year: 2019 Tacrolimus versus cyclosporine for lung transplant recipients in Portugal Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia Source: ERJ Open Res, 8 (1) 00583-2021; 10.1183/23120541.00583-2021 Year: 2022 Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007